▼

Sunday, August 16, 2026

Is gamma linolenic acid Capsules 120mg worth the money?

Gamma-linolenic acid (GLA) is a dietary supplement, not an FDA-approved drug — it has no FDA-approved indication for treating any disease. It is an omega-6 polyunsaturated fatty acid (18:3n-6) found in plant seed oils (evening primrose, borage, black currant seed) and is sold over-the-counter as a nutritional supplement. A 120 mg capsule refers to the GLA content per capsule. All clinical uses below are therefore off-label/investigational, and the evidence is heterogeneous and often inconclusive.[1][2] Thus it will not likely hurt you but whether it’s worth the money is still not clear  


How it works (mechanism)


- GLA is formed from dietary linoleic acid by delta-6-desaturase, then elongated to dihomo-gamma-linolenic acid (DGLA).[3][4]


- DGLA is metabolized by cyclooxygenase and lipoxygenase into anti-inflammatory eicosanoids — prostaglandin E1 (PGE1), series-1 prostaglandins, series-3 leukotrienes, and 15-HETrE — which have anti-inflammatory, immunoregulatory, and antiproliferative properties.[3][4][5]


- Dietary GLA raises tissue DGLA without proportionally raising pro-inflammatory arachidonic acid, shifting the eicosanoid balance toward resolution of inflammation. GLA and its metabolites also modulate gene expression affecting immune function and apoptosis.[5][4]


The following figure shows where GLA and DGLA sit within the omega-6/omega-3 eicosanoid cascade that determines inflammatory tone:




A key caveat: individual response varies with FADS gene variants and cell-specific capacity to convert GLA to DGLA versus arachidonic acid, which likely explains inconsistent clinical trial results and argues against a "one-size-fits-all" approach.[2]


Investigated (off-label) uses


- Rheumatoid arthritis — the most-studied use. A 24-week RCT (1.4 g/d GLA in borage oil) produced clinically meaningful reductions in tender joints (36%), tender joint score (45%), swollen joints (28%), and swollen joint score (41%) versus placebo, and was well tolerated.[1]


- Diabetic peripheral neuropathy — RCTs of 360–480 mg/d GLA (as evening primrose oil) improved nerve conduction and sensory thresholds in mild neuropathy, with better response in patients with lower HbA1c.[6]


- Atopic dermatitis — clinical improvement correlated with rising plasma GLA/DGLA levels.[3]


- Acne vulgaris — 400 mg GLA (borage oil) for 10 weeks reduced lesion number/severity and inflammatory (IL-8) markers.[3]


- Psoriasis and other chronic inflammatory dermatoses — investigated based on anti-inflammatory effects.[3]


- Nonalcoholic fatty liver disease / lipid metabolism — preclinical (cell-model) evidence of reduced lipid deposition via the LKB1-AMPK-mTOR pathway; not established clinically.[7]


- Broader interest in chronic inflammatory conditions (cancer adjuvant, cardiovascular, diabetes) is based largely on mechanistic and animal data.[4]


Why it matters / importance


GLA offers a dietary route to influence the eicosanoid system toward an anti-inflammatory profile, potentially serving as an adjuvant nutrient in chronic inflammatory disease.[4][5] However, it should not be regarded as established therapy for any condition — it is not FDA-approved, doses used in positive trials (often 1.4 g/d) far exceed typical supplement doses like 120 mg, and pooled clinical data remain inconclusive.[1][2]


Practical notes


- Generally well tolerated; the RA trial had no withdrawals for adverse effects.[1]


- As a supplement, product quality and actual GLA content are not FDA-verified.


- Efficacy at 120 mg/capsule is uncertain given that trials showing benefit used substantially higher daily doses.[1][6]



References

  1. Treatment of Rheumatoid Arthritis With Gammalinolenic Acid. Leventhal LJ, Boyce EG, Zurier RB. Annals of Internal Medicine. 1993;119(9):867-73. doi:10.7326/0003-4819-119-9-199311010-00001.
  2. Gamma-Linolenic Acid, Dihommo-Gamma Linolenic, Eicosanoids and Inflammatory Processes. Sergeant S, Rahbar E, Chilton FH. European Journal of Pharmacology. 2016;785:77-86. doi:10.1016/j.ejphar.2016.04.020.
  3. Wound Healing and Omega‐6 Fatty Acids: From Inflammation to Repair. Silva JR, Burger B, Kühl CMC, et al. Mediators of Inflammation. 2018;2018:2503950. doi:10.1155/2018/2503950.
  4. Gamma Linolenic Acid: An Antiinflammatory Omega-6 Fatty Acid. Kapoor R, Huang YS. Current Pharmaceutical Biotechnology. 2006;7(6):531-4. doi:10.2174/138920106779116874.
  5. Importance of Dietary Gamma-Linolenic Acid in Human Health and Nutrition. Fan YY, Chapkin RS. The Journal of Nutrition. 1998;128(9):1411-4. doi:10.1093/jn/128.9.1411.
  6. Integrative neuromuscular medicine: Neuropathy and neuropathic pain: Consider the alternatives. Rowin J. Muscle & Nerve. 2019;60(2):124-136. doi:10.1002/mus.26510.
  7. Γ-Linolenic Acid Prevents Lipid Metabolism Disorder in Palmitic Acid-Treated Alpha Mouse Liver-12 Cells by Balancing Autophagy and Apoptosis via the LKB1-AMPK-mTOR Pathway. Liang Y, Zhang Z, Tu J, et al. Journal of Agricultural and Food Chemistry. 2021;69(29):8257-8267. doi:10.1021/acs.jafc.1c0259

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.